Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix

Review of the literature

Katherine A. O'Hanlan, Gary L. Goldberg, Joan G. Jones, Carolyn D. Runowicz, Laurence Ehrlich, Lorna Rodriguez-Rust

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Neuroendocrine cell carcinoma of the cervix is a virulent tumor associated with an extremely poor prognosis. Even in clinical Stage I disease, there may be subclinical hematogenous and lymphatic metastases with frequent recurrences. Adjuvant postoperative external pelvic radiotherapy has been reported to offer some degree of local control; however, most patients succumb to distant disease. Following radical abdominal hysterectomy and pelvic lymphadenectomy, with confirmation of the neuroendocrine tumor by electron microscopy and immunohistochemical staining, two patients were given adjuvant systemic chemotherapy with concurrent pelvic radiotherapy, employing regimens with documented activity against small cell carcinoma of the lung of neuroendocrine origin. Despite severe myelotoxicity and persistent neuropathy, both patients are alive without clinical evidence of disease at 28+ and 47+ months.

Original languageEnglish (US)
Pages (from-to)167-172
Number of pages6
JournalGynecologic Oncology
Volume43
Issue number2
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Neuroendocrine Carcinoma
Neuroendocrine Cells
Small Cell Carcinoma
Cervix Uteri
Radiotherapy
Lymphatic Metastasis
Neuroendocrine Tumors
Small Cell Lung Carcinoma
Adjuvant Chemotherapy
Lymph Node Excision
Hysterectomy
Electron Microscopy
Therapeutics
Staining and Labeling
Recurrence
Neoplasms

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology
  • Oncology

Cite this

O'Hanlan, Katherine A. ; Goldberg, Gary L. ; Jones, Joan G. ; Runowicz, Carolyn D. ; Ehrlich, Laurence ; Rodriguez-Rust, Lorna. / Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix : Review of the literature. In: Gynecologic Oncology. 1991 ; Vol. 43, No. 2. pp. 167-172.
@article{5fae4415b0c24c9e81f0bedca0b2abf4,
title = "Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix: Review of the literature",
abstract = "Neuroendocrine cell carcinoma of the cervix is a virulent tumor associated with an extremely poor prognosis. Even in clinical Stage I disease, there may be subclinical hematogenous and lymphatic metastases with frequent recurrences. Adjuvant postoperative external pelvic radiotherapy has been reported to offer some degree of local control; however, most patients succumb to distant disease. Following radical abdominal hysterectomy and pelvic lymphadenectomy, with confirmation of the neuroendocrine tumor by electron microscopy and immunohistochemical staining, two patients were given adjuvant systemic chemotherapy with concurrent pelvic radiotherapy, employing regimens with documented activity against small cell carcinoma of the lung of neuroendocrine origin. Despite severe myelotoxicity and persistent neuropathy, both patients are alive without clinical evidence of disease at 28+ and 47+ months.",
author = "O'Hanlan, {Katherine A.} and Goldberg, {Gary L.} and Jones, {Joan G.} and Runowicz, {Carolyn D.} and Laurence Ehrlich and Lorna Rodriguez-Rust",
year = "1991",
month = "1",
day = "1",
doi = "https://doi.org/10.1016/0090-8258(91)90066-E",
language = "English (US)",
volume = "43",
pages = "167--172",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix : Review of the literature. / O'Hanlan, Katherine A.; Goldberg, Gary L.; Jones, Joan G.; Runowicz, Carolyn D.; Ehrlich, Laurence; Rodriguez-Rust, Lorna.

In: Gynecologic Oncology, Vol. 43, No. 2, 01.01.1991, p. 167-172.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix

T2 - Review of the literature

AU - O'Hanlan, Katherine A.

AU - Goldberg, Gary L.

AU - Jones, Joan G.

AU - Runowicz, Carolyn D.

AU - Ehrlich, Laurence

AU - Rodriguez-Rust, Lorna

PY - 1991/1/1

Y1 - 1991/1/1

N2 - Neuroendocrine cell carcinoma of the cervix is a virulent tumor associated with an extremely poor prognosis. Even in clinical Stage I disease, there may be subclinical hematogenous and lymphatic metastases with frequent recurrences. Adjuvant postoperative external pelvic radiotherapy has been reported to offer some degree of local control; however, most patients succumb to distant disease. Following radical abdominal hysterectomy and pelvic lymphadenectomy, with confirmation of the neuroendocrine tumor by electron microscopy and immunohistochemical staining, two patients were given adjuvant systemic chemotherapy with concurrent pelvic radiotherapy, employing regimens with documented activity against small cell carcinoma of the lung of neuroendocrine origin. Despite severe myelotoxicity and persistent neuropathy, both patients are alive without clinical evidence of disease at 28+ and 47+ months.

AB - Neuroendocrine cell carcinoma of the cervix is a virulent tumor associated with an extremely poor prognosis. Even in clinical Stage I disease, there may be subclinical hematogenous and lymphatic metastases with frequent recurrences. Adjuvant postoperative external pelvic radiotherapy has been reported to offer some degree of local control; however, most patients succumb to distant disease. Following radical abdominal hysterectomy and pelvic lymphadenectomy, with confirmation of the neuroendocrine tumor by electron microscopy and immunohistochemical staining, two patients were given adjuvant systemic chemotherapy with concurrent pelvic radiotherapy, employing regimens with documented activity against small cell carcinoma of the lung of neuroendocrine origin. Despite severe myelotoxicity and persistent neuropathy, both patients are alive without clinical evidence of disease at 28+ and 47+ months.

UR - http://www.scopus.com/inward/record.url?scp=0026354318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026354318&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/0090-8258(91)90066-E

DO - https://doi.org/10.1016/0090-8258(91)90066-E

M3 - Article

VL - 43

SP - 167

EP - 172

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -